Trevena, Inc. (NASDAQ:TRVN – Get Free Report)’s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.01 and traded as high as $0.0111. Trevena shares last traded at $0.0111, with a volume of 906 shares.
Trevena Price Performance
The stock has a market cap of $10,644.90, a P/E ratio of 0.00 and a beta of 0.60. The company has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.20.
About Trevena
Trevena, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of biased ligand G protein-coupled receptor (GPCR) selective medicines. By leveraging its proprietary bias-ligand technology platform, Trevena aims to create therapies that preferentially activate beneficial signaling pathways while minimizing engagement of pathways linked to adverse effects. The company’s research efforts target areas of high unmet medical need, including pain management, cardiometabolic disorders and central nervous system conditions.
The company’s lead compound, oliceridine (also known by its brand name OLINVEO), is a G protein-biased μ-opioid receptor agonist designed for the treatment of moderate to severe acute pain in the hospital setting.
See Also
- Five stocks we like better than Trevena
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.
